Gray Market Exit Strategy?

P

Peptide_Update446

Member
Let's discuss what most likely took place here, as industry discussions are being evasive.

Company X built a significant business, reportedly generating hundreds of millions in revenue, by selling research chemicals in a loosely regulated area. Enforcement was infrequent, and penalties were manageable.

However, three things changed at once:

1. The most lucrative products (GLP-1s) became legally hazardous. Recent legislation and numerous warning letters made selling analogs like semaglutide, tirzepatide, and reta a high-risk venture.
2. Enforcement moved beyond warning letters to physical raids. The FDA's raid on Vendor Y's facility sent a clear message.
3. The perception of quality diminished. Independent testing highlighted quality issues, damaging the brand's reputation for providing high-grade products.

Once a fortune has been made, the remaining inventory isn't worth the legal risk, and brand trust is declining, the logical decision is straightforward: shut down the website and walk away. Let someone else face the consequences.

As we mentioned earlier: "Company X earned a substantial amount and exited at the peak. Why engage in a lengthy legal battle with the authorities when you can simply retire? A wise move in the gray market."

This isn't a tragedy; it's a business decision. https://thepeptidelist.substack.com...ad-inside-the?r=7l77vf&_src_ref=another forum
 
I'm skeptical that vendors making mega profits are just going to disappear after making all that cash.

Maybe the website is gone, but in a market where customers willingly pay in crypto or use messaging apps, I don't see them retiring in the Caribbean.
 
I missed the metaphor, I guess. I'm not familiar with that source. Is it a joke site?

I think these vendors are like whack-a-moles. The authorities might shut them down, but they'll just reappear under a different name and using a new channel.
 
When they say 'US Warehouse,' think more like a basement or spare bedroom.
I love the websites showing spotless labs and people in lab coats. 🤣
 
I honestly think I trust stuff sourced directly from overseas more than from a third party here. There are more opportunities in the supply chain for problems to happen.
 
I've heard rumors they're relaunching as a compounding pharmacy under a new name. If they reschedule those peptides, it'll hand them a ready-made market.
 
To play devil's advocate, a study with only 100 or so patients... couldn't the improved cancer rates be from 'healthy user bias?' People taking the drugs might already be healthier in other ways.
 
I read that generic versions should be available soon, too. Super excited because paying out of pocket is insane. Hopefully prices drop significantly.
 
I'm crossing my fingers for lower prices. I'm a type 2 diabetic, and my insurance won't cover it. It's too expensive for me right now, and I've already gained back some weight. I can't wait until it's more affordable!
 
The gray/black distinction is interesting and usually comes down to regulatory ambiguity. Like with sema compounding - technically legal until it isn't. The community has been navigating that forever.
 
You must log in or register to reply here.
Back
Top